Home / Companies / Sarepta Therapeutics, Inc. / 6 Jun 2024
Sarepta Therapeutics, Inc.: meeting of 6 Jun 2024
Votes reported on Form N-PX, item by item
601 Form N-PX filers reported votes at the Sarepta Therapeutics, Inc. meeting of 6 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 90.0% of reported votes for; 55 filers withheld from or voted against at least one nominee.
1,748 vote records from 227 filers. 14 of the 226 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. No share split is published for this item. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
883 vote records from 595 filers. 108 of the 574 filers that marked the item either way voted against management. 21 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. No share split is published for this item. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
438 vote records from 227 filers. 11 of the 226 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. No share split is published for this item. How that is decided
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Sarepta Therapeutics, Inc. meeting?
601 Form N-PX filers reported votes at the meeting of 6 Jun 2024. On say-on-pay, 108 of 574 voted against management (18.8%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Sarepta Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Sarepta Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Sarepta Therapeutics, Inc. with a meeting date within three days of 6 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.